Efficacy and Safety of Weekly Dalbavancin Therapy for Catheter-Related Bloodstream Infection Caused by Gram-Positive Pathogens

2005293 citationsJournal Articlebronze Open Access

Authors

Issam Raad

Rabih O. Darouiche

José A. Vázquez · Harper University Hospital

Arnold Lentnek · WellStar Kennestone Hospital

Ray Hachem

Hend Hanna · The University of Texas MD Anderson Cancer Center

Beth P. Goldstein

Tim Henkel

Elyse Seltzer

Abstract

Dalbavancin thus appears to be an effective and well-tolerated treatment option for adult patients with CR-BSIs caused by CoNS and S. aureus, including MRSA.

Topics & Keywords

Antimicrobial Resistance in Staphylococcus Bacterial Identification and Susceptibility Testing Central Venous Catheters and Hemodialysis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Infectious Diseases

Volume 40, Issue 3, pp. 374-380

DOI: 10.1086/427283

Field-Weighted Citation Impact: 12.45

Command Palette